ICU Medical, Inc.

NASDAQ:ICUI

Medical - Instruments & Supplies

Healthcare
$178.48 +0.64%

+$0.89 today

Market cap
$4.46B
Beta
0.78
P/E (TTM)
74.2
EPS (TTM)
$1.87
52W Low $107.00High $160.29

Volume 0.21M

Average 0.29M

ICUI Net Margin

Net income as a percentage of revenue, showing how much of each sales dollar becomes profit.

ICU Medical, Inc.NASDAQ: ICUI

Net Margin · Q2 FY2026 · quarter ended Jun 2026

Net margin narrows to 3.5%

Net margin was 3.5% in Q2 FY2026, down 3.0 pp from a year earlier. On a trailing-twelve-month basis it was 1.4%, up 3.0 pp year over year. Over 3 fiscal years it widened by 3.3 pp.

Context

  • Net margin widened in 2 of the last 3 fiscal years.
  • FY2025 was the highest level in the 4 fiscal years shown.

What to watch

Whether net margin reaches the consensus estimate from 7 analysts of 10.2% for the fiscal year ending Dec 2026, up from 0.0% in FY2025.

Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.

Latest quarterJun 2026
3.5%-2.2 pp QoQ
Last fiscal yearDec 2025
0.0%+5.0 pp YoY
LTMJun 2026
1.4%+3.0 pp YoY
Net Margin past and forecast change by horizon
Horizon Past Forecast Difference
Quarter-3.0 pp+10.4 pp+13.3 pp
1 year+5.0 pp+10.1 pp+5.2 pp
3 years+3.3 pp+11.3 pp+8.0 pp
5 years+11.7 pp—
10 years——

Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.

Net Margin history

Percent of revenue · from the income statement

Latest · FY2025
0.0%
Year-over-year change
+5.0pp
Reported Analyst consensus estimate Further estimates hidden. Sign in to unlock

Net Margin vs competitors

How ICUI compares with its peers on the latest reported figures

  • ICUI's LTM Jun 2026 net margin of 1.4% is the 2nd highest of the 5 companies compared; the peer median is -7.3%.
  • Its year-over-year change of +3.0 pp is the 2nd highest of 5, against a peer median of -4.9 pp.
  • Over three fiscal years its change of +3.3 pp compares with a peer median of +7.0 pp.
ICUI Competitors Peer median
Net Margin for ICUI and competitors
Company Period LTM level YoY 3-year change
BDXBecton, Dickinson and CompanyLTM Sep 20265.7% -2.0 pp-1.8 pp
ICUIICU Medical, Inc.LTM Jun 20261.4% +3.0 pp+3.3 pp
KRMDKORU Medical Systems, Inc.LTM Mar 2026-5.3% +9.8 pp+24.6 pp
BAXBaxter International Inc.LTM Jun 2026-9.3% -7.8 pp+15.7 pp
TFXTeleflex IncorporatedLTM Jun 2026-39.6% -45.9 pp-58.5 pp
Peer median (excluding ICUI) -7.3%-4.9 pp+7.0 pp

Competitors are the stored peer set for ICUI. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue1.32B2.28B2.26B2.38B2.23B
Cost of Revenue824.82M1.58B1.52B1.56B1.41B
Gross Profit491.49M697.76M739.87M824.78M819.66M
Gross Margin37.3%30.6%32.8%34.6%36.8%
Research & Development47.5M92.98M85.34M88.62M87.5M
Selling, General & Admin302.58M608.35M606.69M638.76M625.21M
Operating Expenses368.25M740.66M717.05M781.82M712.71M
Depreciation & Amortization89.7M235.15M228.77M219.51M200.74M
EBITDA213.86M191.55M253.2M260.04M309.29M
EBITDA Margin16.2%8.4%11.2%10.9%13.9%
Operating Income123.25M(42.9M)22.83M42.96M106.95M
Operating Margin9.4%-1.9%1.0%1.8%4.8%
Interest Income2.84M4.43M7.51M10.79M10.31M
Interest Expense858K70.81M102.73M106.54M105.38M
Other Income / Expenses(59K)(71.51M)(101.12M)(108.98M)(103.78M)
Income Before Tax123.19M(114.41M)(78.3M)(66.01M)3.17M
Pre-Tax Margin9.4%-5.0%-3.5%-2.8%0.1%
Income Tax Expense20.05M(40.12M)(48.64M)51.68M2.44M
Net Income103.14M(74.29M)(29.66M)(117.69M)732K
Net Margin7.8%-3.3%-1.3%-4.9%0.0%
EPS (Basic)4.86(3.11)(1.23)(4.83)0.03
EPS (Diluted)4.74(3.11)(1.23)(4.83)0.03
Weighted Avg Shares21.21M23.87M24.09M24.39M24.64M
Weighted Avg Shares (Diluted)21.78M23.87M24.09M24.39M24.9M

ICU Medical, Inc.

NASDAQ:ICUI

Intrinsic Alpha fair value

Locked

Current Price

$178.48

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.